Last Year's Physician Survey: Barriers to Understanding Biosimilars
Survey shows education will be needed to convince physicians of the value of biosimilar agents.
Amgen's Amjevita at Risk for 2017 Launch
Amgen will await the outcome of its patent litigation with AbbVie before launching Amjevita.
House of Representatives Approves Bipartisan 21st Century Cures Legislation
